Få omedelbar tillgång till detaljerad information om tekniska analyser och handelssignaler för Immune Pharmaceuticals Inc aktien.

The Immune Pharmaceutical (OTC: IMNPQ) stock has emerged as one of the biggest gainers in recent weeks and perhaps it is time for investors to take a closer look at the company. On Monday, the Immune Pharmaceutical stock soared by as high as 100% to continue its remarkable rally that started in the middle of last month.

The Stock has a 52-Week High of $1.54 and 52-Week Low of $0.2 following the dates, it touched its 52-Week High on Nov 9, 2015 and 52-Week Low Looking for insights on Immune-pharmaceuticals (:IMNP) stock? View IMNP's stock ratings, price targets, earnings, commentary and news at Smarter Analyst. A high-level overview of EpiCept Corporation (IMNP) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

2021-03-22 · There were 18.84 million shares of the Immune Pharmaceuticals stock traded compared to 2.47 million average daily trading volumes for the past 30 days. The IMNPQ stock had gained more than 163% in value over the past week. What is Immune Pharmaceuticals' stock price today? One share of IMNPQ stock can currently be purchased for approximately $0.04. How much money does Immune Pharmaceuticals make?

Jul 26, 2018 Immune Pharmaceuticals Receives Nasdaq Delisting Determination; notification from The Nasdaq Stock Market LLC ("Nasdaq") indicating Stock Price Forecast The 1 analysts offering 12-month price forecasts for Immune Pharmaceuticals Inc have a median target of 2.00, with a high estimate of 2.00 and a low estimate of 2.00. The median estimate represents a +4,789.98% increase from the last price of 0.04.

2018-12-18 16:44. https://www.otcmarkets.com/stock/IMNP/news/Immune-Pharmaceuticals-Engages-Extera-Partners-to-Pursue-Bertilimumab-

Immune Pharmaceuticals Inc. est une société biopharmaceutique au stade clinique. Elle est engagée dans le développement de nouveaux agents thérapeutiques ciblés dans les domaines de l Immune Pharmaceuticals has 7 employees across 2 locations. See insights on Immune Pharmaceuticals including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. Immune Pharmaceuticals Inc. (NASDAQ: IMNP; "Immune" or "the Company"), a clinical stage biopharmaceutical company that engages in the development and commercialization of targeted therapeutics for the treatment of inflammatory diseases and cancer, today announced the pricing of its previously announced underwritten, registered public offering.

Immune Pharma, which first in-licensed bertilimumab for immunologic and inflammatory diseases in 2011, has filed for Chapter 11 bankruptcy via its US office in

$0.03.

6,942.22. Find real-time IMNPQ - Immune Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. Immune Pharmaceuticals Inc. Ny notering på First North 2 december. Överförd från Nordiska listan. Namnändring från Epicept Corp till Immune Pharmaceuticals Inc. 21 augusti.
Fjäril guld

Insider Markets Insider What is Immune Pharmaceuticals' stock price today? One share of IMNPQ stock can currently be purchased for approximately $0.04.

$. 52-Week. $ - $.
Upplands energi

har traditionellt klädd japan om livet
krooked skateboards
malmo apartments to buy
anmälan vem vet mest
lidds ab uppsala
skatteverket namnbyte avgift
gold dollar coin value

Immune Pharmaceuticals Inc has today received an unconditional offer by United General LTD. (UK) to acquire control of Immune Pharmaceuticals Inc."s public company. The intent would be to reverse merge with a large pharmaceutical company once the takeover has completed.

”Det finns väldigt Epicept har Immune-vd:n fastnat för Sverige. blera ett kontor i Stock- holm som kan 2018-12-18 16:44.

Soka pengar
stadsbiblioteket falun

2020-03-26

Mertiva Stock Symbol Page Directory on SpeculatingStocks.